Literature DB >> 28673099

Suicidal Ideation and Schizophrenia: Contribution of Appraisal, Stigmatization, and Cognition.

Emmanuel Stip1, Jean Caron2, Michel Tousignant3, Yves Lecomte4.   

Abstract

OBJECTIVE: To predict suicidal ideation in people with schizophrenia, certain studies have measured its relationship with the variables of defeat and entrapment. The relationships are positive, but their interactions remain undefined. To further their understanding, this research sought to measure the relationship between suicidal ideation with the variables of loss, entrapment, and humiliation.
METHOD: The convenience sample included 30 patients with schizophrenia spectrum disorders. The study was prospective (3 measurement times) during a 6-month period. Results were analyzed by stepwise multiple regression.
RESULTS: The contribution of the 3 variables to the variance of suicidal ideation was not significant at any of the 3 times (T1: 16.2%, P = 0.056; T2: 19.9%, P = 0.117; T3: 11.2%, P = 0.109). Further analyses measured the relationship between the variables of stigmatization, perceived cognitive dysfunction, symptoms, depression, self-esteem, reason to live, spirituality, social provision, and suicidal ideation. Stepwise multiple regression demonstrated that the contribution of the variables of stigmatization and perceived cognitive dysfunction to the variance of suicidal ideation was significant at all 3 times (T1: 41.7.5%, P = 0.000; T2: 35.2%, P = 0.001; T3: 21.5%, P = 0.012). Yet, over time, the individual contribution of the variables changed: T1, stigmatization (β = 0.518; P = 0.002); T2, stigmatization (β = 0.394; P = 0.025) and perceived cognitive dysfunction (β = 0.349; P = 0.046). Then, at T3, only perceived cognitive dysfunction contributed significantly to suicidal ideation (β = 0.438; P = 0.016).
CONCLUSION: The results highlight the importance of the contribution of the variables of perceived cognitive dysfunction and stigmatization in the onset of suicidal ideation in people with schizophrenia spectrum disorders.

Entities:  

Keywords:  entrapment; humiliation; loss; perceived cognitive dysfunction; schizophrenia; stigmatization; suicidal ideation

Mesh:

Year:  2017        PMID: 28673099      PMCID: PMC5638189          DOI: 10.1177/0706743717715207

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  53 in total

Review 1.  Insight and suicidal behavior in first-episode schizophrenia.

Authors:  Ingrid Melle; Elizabeth Ann Barrett
Journal:  Expert Rev Neurother       Date:  2012-03       Impact factor: 4.618

2.  Suicidality before and in the early phases of first episode psychosis.

Authors:  Elizabeth A Barrett; Kjetil Sundet; Ann Faerden; Ragnar Nesvåg; Ingrid Agartz; Roar Fosse; Erlend Mork; Nils Eiel Steen; Ole A Andreassen; Ingrid Melle
Journal:  Schizophr Res       Date:  2010-06       Impact factor: 4.939

3.  Coping patterns as a valid presentation of the diversity of coping responses in schizophrenia patients.

Authors:  Michael S Ritsner; Anatoly Gibel; Alexander M Ponizovsky; Evgeny Shinkarenko; Yael Ratner; Rena Kurs
Journal:  Psychiatry Res       Date:  2006-10-02       Impact factor: 3.222

4.  Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals.

Authors:  Beate Schulze; Matthias C Angermeyer
Journal:  Soc Sci Med       Date:  2003-01       Impact factor: 4.634

5.  Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression.

Authors:  M Birchwood; Z Iqbal; P Chadwick; P Trower
Journal:  Br J Psychiatry       Date:  2000-12       Impact factor: 9.319

6.  Understanding suicidal ideation in psychosis: findings from the Psychological Prevention of Relapse in Psychosis (PRP) trial.

Authors:  L Fialko; D Freeman; P E Bebbington; E Kuipers; P A Garety; G Dunn; D Fowler
Journal:  Acta Psychiatr Scand       Date:  2006-09       Impact factor: 6.392

Review 7.  Suicide and awareness of illness in schizophrenia: an overview.

Authors:  Maurizio Pompili; Amedeo Ruberto; Giorgio D Kotzalidis; Paolo Girardi; Roberto Tatarelli
Journal:  Bull Menninger Clin       Date:  2004

8.  Suicide attempt and suicidal ideation and their associations with demographic and clinical correlates and quality of life in Chinese schizophrenia patients.

Authors:  Fang Yan; Yu-Tao Xiang; Ye-Zhi Hou; Gabor S Ungvari; Lisa B Dixon; Sandra S M Chan; Edwin H M Lee; Weng-Yong Li; Wen-Xiu Li; Yu-Ling Zhu; Helen F K Chiu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-07-31       Impact factor: 4.328

9.  Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension.

Authors:  Amresh Shrivastava; Megan E Johnston; Nilesh Shah; Marco Innamorati; Larry Stitt; Meghana Thakar; David Lester; Maurizio Pompili
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-05       Impact factor: 2.570

Review 10.  Suicide in the Early Stage of Schizophrenia.

Authors:  Antonio Ventriglio; Alessandro Gentile; Iris Bonfitto; Eleonora Stella; Massimo Mari; Luca Steardo; Antonello Bellomo
Journal:  Front Psychiatry       Date:  2016-06-27       Impact factor: 4.157

View more
  3 in total

1.  Self-stigma in Serious Mental Illness: A Systematic Review of Frequency, Correlates, and Consequences.

Authors:  Julien Dubreucq; Julien Plasse; Nicolas Franck
Journal:  Schizophr Bull       Date:  2021-08-21       Impact factor: 9.306

2.  Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition.

Authors:  Lindsay A Bornheimer; Jessica A Wojtalik; Juliann Li; Derin Cobia; Matthew J Smith
Journal:  Schizophr Res       Date:  2021-01-23       Impact factor: 4.939

3.  Neurocognition and the Suicidal Process.

Authors:  S B Rutter; N Cipriani; E C Smith; E Ramjas; D H Vaccaro; M Martin Lopez; W R Calabrese; D Torres; P Campos-Abraham; M Llaguno; E Soto; M Ghavami; M M Perez-Rodriguez
Journal:  Curr Top Behav Neurosci       Date:  2020
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.